Investment in vaccine development is lagging, report finds
The COVID vaccines have saved approximately 20 million lives globally and produced substantial revenue for pharmaceutical companies. Despite the significant investment in these vaccines, funding for experimental vaccines for various diseases has remained low. The report by the Biotechnology Innovation Organization (BIO) highlighted that only 3.4% of all venture capital raised for biopharma companies in…